挤压细胞纳米囊泡与外泌体在分子载荷和再生潜力方面的比较。
Comparison of extruded cell nanovesicles and exosomes in their molecular cargos and regenerative potentials.
作者信息
Wang Xianyun, Hu Shiqi, Zhu Dashuai, Li Junlang, Cheng Ke, Liu Gang
机构信息
Department of Cardiology, The First Hospital of Hebei Medical University, Shijiazhuang, 050000 China.
Scientific Research Data Center, The First Hospital of Hebei Medical University, Shijiazhuang, 050000 China.
出版信息
Nano Res. 2023;16(5):7248-7259. doi: 10.1007/s12274-023-5374-3. Epub 2023 Feb 28.
Abstract
UNLABELLED
Extracellular vesicles (EVs) generated from mesenchymal stem cells (MSCs) play an essential role in modulating cell-cell communication and tissue regeneration. The clinical translation of EVs is constrained by the poor yield of EVs. Extrusion has recently become an effective technique for producing a large scale of nanovesicles (NVs). In this study, we systematically compared MSC NVs (from extrusion) and EVs (from natural secretion). Proteomics and RNA sequencing data revealed that NVs resemble MSCs more closely than EVs. Additionally, microRNAs in NVs are related to cardiac repair, fibrosis repression, and angiogenesis. Lastly, intravenous delivery of MSC NVs improved heart repair and cardiac function in a mouse model of myocardial infarction.
ELECTRONIC SUPPLEMENTARY MATERIAL
Supplementary material (Figs. S1-S4) is available in the online version of this article at 10.1007/s12274-023-5374-3.
摘要
未标记
间充质干细胞（MSC）产生的细胞外囊泡（EV）在调节细胞间通讯和组织再生中起重要作用。EV的临床转化受到其产量低的限制。挤压法最近已成为一种大规模生产纳米囊泡（NV）的有效技术。在本研究中，我们系统地比较了MSC NV（来自挤压法）和EV（来自自然分泌）。蛋白质组学和RNA测序数据显示，NV比EV更类似于MSC。此外，NV中的微小RNA与心脏修复、纤维化抑制和血管生成有关。最后，在心肌梗死小鼠模型中，静脉注射MSC NV可改善心脏修复和心脏功能。
电子补充材料
补充材料（图S1 - S4）可在本文的在线版本中获取，链接为10.1007/s12274-023-5374-3。
相似文献
1
Comparison of extruded cell nanovesicles and exosomes in their molecular cargos and regenerative potentials.
Nano Res. 2023;16(5):7248-7259. doi: 10.1007/s12274-023-5374-3. Epub 2023 Feb 28.
2
Extruded Mesenchymal Stem Cell Nanovesicles Are Equally Potent to Natural Extracellular Vesicles in Cardiac Repair.
ACS Appl Mater Interfaces. 2021 Dec 1;13(47):55767-55779. doi: 10.1021/acsami.1c08044. Epub 2021 Nov 18.
3
High yield engineered nanovesicles from ADSC with enriched miR-21-5p promote angiogenesis in adipose tissue regeneration.
Biomater Res. 2022 Dec 17;26(1):83. doi: 10.1186/s40824-022-00325-y.
4
Mesenchymal Stem Cell-derived Nanovesicles as a Credible Agent for Therapy of Pulmonary Hypertension.
Am J Respir Cell Mol Biol. 2022 Jul;67(1):61-75. doi: 10.1165/rcmb.2021-0415OC.
5
Mesenchymal stromal cell-derived nanovesicles ameliorate bacterial outer membrane vesicle-induced sepsis via IL-10.
Stem Cell Res Ther. 2019 Aug 1;10(1):231. doi: 10.1186/s13287-019-1352-4.
6
Biofabrication of Cell-Derived Nanovesicles: A Potential Alternative to Extracellular Vesicles for Regenerative Medicine.
Cells. 2019 Nov 25;8(12):1509. doi: 10.3390/cells8121509.
7
Nanovesicles derived from iron oxide nanoparticles-incorporated mesenchymal stem cells for cardiac repair.
Sci Adv. 2020 May 1;6(18):eaaz0952. doi: 10.1126/sciadv.aaz0952. eCollection 2020 May.
8
Stem Cell-Engineered Nanovesicles Exert Proangiogenic and Neuroprotective Effects.
Materials (Basel). 2021 Feb 25;14(5):1078. doi: 10.3390/ma14051078.
9
Melatonin Engineered Adipose-Derived Biomimetic Nanovesicles Regulate Mitochondrial Functions and Promote Myocardial Repair in Myocardial Infarction.
Front Cardiovasc Med. 2022 Mar 23;9:789203. doi: 10.3389/fcvm.2022.789203. eCollection 2022.
10
Scalable Generation of Nanovesicles from Human-Induced Pluripotent Stem Cells for Cardiac Repair.
Int J Mol Sci. 2022 Nov 18;23(22):14334. doi: 10.3390/ijms232214334.
引用本文的文献
1
Comparison of the Cytotoxicity, Internalization and Anti-Cancer Drug Delivery Efficacy of Nature Killer Cell Derived Nanovesicles and Extracellular Vesicles.
Int J Nanomedicine. 2025 Sep 2;20:10683-10700. doi: 10.2147/IJN.S527756. eCollection 2025.
2
Extruded nanovesicles derived from umbilical cord mesenchymal stem cells exhibit No tumorigenic potential.
Bioact Mater. 2025 Jul 3;52:866-876. doi: 10.1016/j.bioactmat.2025.06.056. eCollection 2025 Oct.
3
Stromal-platelet membrane-inspired nanoparticles (SPIN) for targeted heart repair.
Bioact Mater. 2025 Jul 7;53:45-57. doi: 10.1016/j.bioactmat.2025.06.055. eCollection 2025 Nov.
4
Engineering small extracellular vesicles: Unlocking the brain's secret passage for central nervous system therapies.
J Cereb Blood Flow Metab. 2025 Jun 19:271678X251348816. doi: 10.1177/0271678X251348816.
5
Human induced pluripotent stem cell derived nanovesicles for cardiomyocyte protection and proliferation.
Bioact Mater. 2025 May 2;50:585-602. doi: 10.1016/j.bioactmat.2025.04.017. eCollection 2025 Aug.
6
Identification of genetically engineered strategies to manipulate nano-platforms presenting immunotherapeutic ligands for alleviating primary ovarian insufficiency progression.
Cell Commun Signal. 2025 May 28;23(1):246. doi: 10.1186/s12964-025-02226-8.
7
Platelet Membrane and miR-181a-5p Doubly Optimized Nanovesicles Enhance Cardiac Repair Post-Myocardial Infarction through Macrophage Polarization.
ACS Appl Mater Interfaces. 2025 Mar 19;17(11):16520-16532. doi: 10.1021/acsami.4c19325. Epub 2025 Mar 10.
8
Overcoming drug resistance through extracellular vesicle-based drug delivery system in cancer treatment.
Cancer Drug Resist. 2024 Dec 12;7:50. doi: 10.20517/cdr.2024.107. eCollection 2024.
9
Role of PCBP2 in regulating nanovesicles loaded with curcumin to mitigate neuroferroptosis in neural damage caused by heat stroke.
J Nanobiotechnology. 2024 Dec 27;22(1):800. doi: 10.1186/s12951-024-02889-4.
10
Extracellular vesicle mimetics as delivery vehicles for oligonucleotide-based therapeutics and plasmid DNA.
Front Bioeng Biotechnol. 2024 Oct 17;12:1437817. doi: 10.3389/fbioe.2024.1437817. eCollection 2024.
本文引用的文献
1
Cell-derived nanovesicles prepared by membrane extrusion are good substitutes for natural extracellular vesicles.
Extracell Vesicle. 2022 Dec;1. doi: 10.1016/j.vesic.2022.100004. Epub 2022 Jul 1.
2
Inhalable exosomes outperform liposomes as mRNA and protein drug carriers to the lung.
Extracell Vesicle. 2022 Dec;1:100002. doi: 10.1016/j.vesic.2022.100002. Epub 2022 Jun 16.
3
Intrapericardial Exosome Therapy Dampens Cardiac Injury via Activating Foxo3.
Circ Res. 2022 Oct 28;131(10):e135-e150. doi: 10.1161/CIRCRESAHA.122.321384. Epub 2022 Oct 13.
4
Decoy Exosomes Offer Protection Against Chemotherapy-Induced Toxicity.
Adv Sci (Weinh). 2022 Nov;9(32):e2203505. doi: 10.1002/advs.202203505. Epub 2022 Sep 4.
5
Inhalable dry powder mRNA vaccines based on extracellular vesicles.
Matter. 2022 Sep 7;5(9):2960-2974. doi: 10.1016/j.matt.2022.06.012. Epub 2022 Jul 11.
6
Boosting extracellular vesicle secretion.
Biotechnol Adv. 2022 Oct;59:107983. doi: 10.1016/j.biotechadv.2022.107983. Epub 2022 May 16.
7
Engineering strategies for customizing extracellular vesicle uptake in a therapeutic context.
Stem Cell Res Ther. 2022 Mar 28;13(1):129. doi: 10.1186/s13287-022-02806-2.
8
Metformin Bicarbonate-Mediated Efficient RNAi for Precise Targeting of Deficiency in Colon and Rectal Cancers.
Nano Today. 2022 Apr;43. doi: 10.1016/j.nantod.2022.101406. Epub 2022 Feb 1.
9
Extruded Mesenchymal Stem Cell Nanovesicles Are Equally Potent to Natural Extracellular Vesicles in Cardiac Repair.
ACS Appl Mater Interfaces. 2021 Dec 1;13(47):55767-55779. doi: 10.1021/acsami.1c08044. Epub 2021 Nov 18.
10
Cell-mimicking nanodecoys neutralize SARS-CoV-2 and mitigate lung injury in a non-human primate model of COVID-19.
Nat Nanotechnol. 2021 Aug;16(8):942-951. doi: 10.1038/s41565-021-00923-2. Epub 2021 Jun 17.
Zotero 插件